Quick Takeaways
- Gregory Scott Duncan has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $799,981.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Gregory Scott Duncan
- Location
- Alpharetta, GA
- Summary
- The estimated net worth of Gregory Scott Duncan is at least $799,981 dollars as of 06 Mar 2026. Gregory Scott Duncan is the Director of CorMedix Inc. and owns shares of CorMedix Inc. (CRMD) stock worth about $800K.
- Signature
- /s/ Greg Duncan
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Gregory Scott Duncan and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: CorMedix Inc. ($799,981).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Gregory Scott Duncan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CRMD | CorMedix Inc. | Director | $799,981 | 26 Jan 2026 | ||
| DWTX | Dogwood Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | 05 Mar 2026 |
Insider Transactions Reported by Gregory Scott Duncan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.